These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21764185)

  • 21. Synthesis and structure-activity relationship of 1H-indole-3-carboxylic acid pyridine-3-ylamides: a novel series of 5-HT2C receptor antagonists.
    Park CM; Kim SY; Park WK; Park NS; Seong CM
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3844-7. PubMed ID: 18602261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
    Koike T; Hoashi Y; Takai T; Nakayama M; Yukuhiro N; Ishikawa T; Hirai K; Uchikawa O
    J Med Chem; 2011 May; 54(9):3436-44. PubMed ID: 21473625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
    Tuccinardi T; Schenone S; Bondavalli F; Brullo C; Bruno O; Mosti L; Zizzari AT; Tintori C; Manetti F; Ciampi O; Trincavelli ML; Martini C; Martinelli A; Botta M
    ChemMedChem; 2008 Jun; 3(6):898-913. PubMed ID: 18338422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a Potent and Orally Bioavailable Melatonin Receptor Agonist.
    Hoashi Y; Takai T; Kosugi Y; Nakashima M; Nakayama M; Hirai K; Uchikawa O; Koike T
    J Med Chem; 2021 Mar; 64(6):3059-3074. PubMed ID: 33682410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological evaluation of novel octahydro-1H-pyrido[1,2-a]pyrazine as mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Graczyk TM; Belanger S; Seida PR; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7290-306. PubMed ID: 17149859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
    Ettaoussi M; Péres B; Klupsch F; Delagrange P; Boutin JA; Renard P; Caignard DH; Chavatte P; Berthelot P; Lesieur D; Yous S
    Bioorg Med Chem; 2008 May; 16(9):4954-62. PubMed ID: 18372181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands.
    Pittalà V; Modica M; Romeo G; Materia L; Salerno L; Siracusa M; Cagnotto A; Mereghetti I; Russo F
    Farmaco; 2005 Sep; 60(9):711-20. PubMed ID: 16039654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands.
    Yous S; Durieux-Poissonnier S; Lipka-Belloli E; Guelzim H; Bochu C; Audinot V; Boutin JA; Delagrange P; Bennejean C; Renard P; Lesieur D
    Bioorg Med Chem; 2003 Mar; 11(5):753-9. PubMed ID: 12538005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydropyrrole[2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: mapping of the receptor binding pocket by in silico docking studies.
    Di Fabio R; Arban R; Bernasconi G; Braggio S; Blaney FE; Capelli AM; Castiglioni E; Donati D; Fazzolari E; Ratti E; Feriani A; Contini S; Gentile G; Ghirlanda D; Sabbatini FM; Andreotti D; Spada S; Marchioro C; Worby A; St-Denis Y
    J Med Chem; 2008 Nov; 51(22):7273-86. PubMed ID: 18975927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-[(4-phenylpiperazin-1-yl)methyl]imidazo(di)azines as selective D4-ligands. Induction of penile erection by 2-[4-(2-methoxyphenyl)piperazin-1-ylmethyl]imidazo[1,2-a]pyridine (PIP3EA), a potent and selective D4 partial agonist.
    Enguehard-Gueiffier C; Hübner H; El Hakmaoui A; Allouchi H; Gmeiner P; Argiolas A; Melis MR; Gueiffier A
    J Med Chem; 2006 Jun; 49(13):3938-47. PubMed ID: 16789750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists.
    Kishino H; Moriya M; Sakuraba S; Sakamoto T; Takahashi H; Suzuki T; Moriya R; Ito M; Iwaasa H; Takenaga N; Ishihara A; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4589-93. PubMed ID: 19615899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationship of novel benzoxazole derivatives as melatonin receptor agonists.
    Sun LQ; Chen J; Bruce M; Deskus JA; Epperson JR; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3799-802. PubMed ID: 15203165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain.
    Ishikawa M; Watanabe T; Kudo T; Yokoyama F; Yamauchi M; Kato K; Kakui N; Sato Y
    J Med Chem; 2010 Sep; 53(17):6445-56. PubMed ID: 20690643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.
    Sun LQ; Chen J; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1197-200. PubMed ID: 14980664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents.
    Ismail MA; Brun R; Wenzler T; Tanious FA; Wilson WD; Boykin DW
    J Med Chem; 2004 Jul; 47(14):3658-64. PubMed ID: 15214792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
    Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
    J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
    J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
    J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel (E)-alpha-[(1H-indol-3-yl)methylene]benzeneacetic acids as endothelin receptor ligands.
    Pittalà V; Romeo G; Materia L; Salerno L; Siracusa MA; Modica M; Mereghetti I; Cagnotto A; Russo F
    Farmaco; 2005 Sep; 60(9):731-8. PubMed ID: 16043172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.